Foghorn Therapeutics Inc.: H.C. Wainwright cuts target price to $5 from $13
FHTX•H.C. Wainwright cut its target price for Foghorn Therapeutics to $5 from $13.
Related News
EU fully rejects any ban on diesel, EU spokesperson says
USO•
KKR & Co. initiates coverage with equal weight rating and $97 target price
KKR•
Trilogy Metals reports third-quarter 2026 financial results
TMQ•
SkyWest, Inc.: TD Cowen cuts target price to $116 from $123
SKYW•
Acco Brands announces closing of the Trust acquisition
ACCO•